IRIS
TETI, ANNA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.451
EU - Europa 5.797
AS - Asia 5.689
SA - Sud America 607
AF - Africa 72
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 22.630
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.335
SG - Singapore 2.191
CN - Cina 1.382
IE - Irlanda 1.176
RU - Federazione Russa 1.140
SE - Svezia 787
TR - Turchia 689
HK - Hong Kong 676
DE - Germania 619
BR - Brasile 530
IT - Italia 516
GB - Regno Unito 446
VN - Vietnam 401
UA - Ucraina 390
FR - Francia 311
FI - Finlandia 219
IN - India 92
JP - Giappone 65
CA - Canada 54
BD - Bangladesh 38
MX - Messico 35
NL - Olanda 33
BE - Belgio 30
AR - Argentina 29
PL - Polonia 26
IQ - Iraq 25
ZA - Sudafrica 25
ES - Italia 22
LT - Lituania 16
ID - Indonesia 15
MA - Marocco 15
VE - Venezuela 15
AT - Austria 13
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 11
IL - Israele 11
EC - Ecuador 9
JO - Giordania 9
PK - Pakistan 9
SA - Arabia Saudita 9
KR - Corea 8
AU - Australia 7
CO - Colombia 7
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
KE - Kenya 6
BG - Bulgaria 5
GR - Grecia 5
HN - Honduras 5
PE - Perù 5
PH - Filippine 5
AL - Albania 4
KZ - Kazakistan 4
MY - Malesia 4
PT - Portogallo 4
RO - Romania 4
SN - Senegal 4
TN - Tunisia 4
BB - Barbados 3
CR - Costa Rica 3
DZ - Algeria 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
UY - Uruguay 3
BH - Bahrain 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
BZ - Belize 2
CH - Svizzera 2
CI - Costa d'Avorio 2
ET - Etiopia 2
EU - Europa 2
IR - Iran 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AM - Armenia 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
Totale 22.617
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.500
Singapore 1.318
Chandler 1.288
Dublin 1.173
San Jose 1.007
Dallas 740
Hong Kong 669
Boardman 533
Ashburn 496
Santa Clara 486
The Dalles 324
Izmir 321
San Mateo 301
Nanjing 281
Wilmington 278
New York 249
Council Bluffs 221
Lawrence 201
Princeton 201
Moscow 195
Lauterbourg 154
Ann Arbor 140
Beijing 136
Ho Chi Minh City 131
Woodbridge 111
Milan 104
Los Angeles 94
Hanoi 93
Nanchang 92
Seattle 88
Shenyang 87
Hefei 75
L'aquila 69
Des Moines 67
Mountain View 67
Verona 60
Tianjin 59
Tokyo 59
Falls Church 57
São Paulo 50
L’Aquila 49
Hebei 47
Bremen 43
Jiaxing 43
Kunming 43
Shanghai 43
Rome 42
Munich 39
Dearborn 34
Kitzingen 33
Orem 33
Philadelphia 32
Ningbo 31
Falkenstein 30
Changsha 28
Columbus 28
Guangzhou 28
Phoenix 28
Frankfurt am Main 27
Chennai 26
Jinan 26
Norwalk 25
Brussels 24
Brooklyn 22
Houston 22
San Francisco 22
Helsinki 21
Warsaw 21
Zhengzhou 21
Nuremberg 20
Chicago 19
Montreal 19
Pune 19
Da Nang 18
Dong Ket 18
London 18
Toronto 18
Johannesburg 16
Mexico City 16
Belo Horizonte 15
Fremont 14
Manchester 14
Pescara 14
Stockholm 14
Boston 13
Denver 13
Rio de Janeiro 13
Tappahannock 13
Turku 13
Amsterdam 12
Ankara 12
Atlanta 12
Brno 12
Lanzhou 12
Lappeenranta 12
Mumbai 12
Paris 12
Taizhou 12
Biên Hòa 11
Poplar 11
Totale 14.933
Salva come PNG Salva come JPEG
Nome #
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 204
SMALL INTERFERING RNA (siRNA) PER LA TERAPIA DELL’OSTEOPETROSI AUTOSOMICA DOMINANTE DI TIPO 2 (ADO2) CAUSATA DA MUTAZIONE DEL GENE CLCN7 (ADO2 CLCN7-DIPENDENTE) 183
Osteoclast-poor human osteopetrosis due to mutations in RANKL 182
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 180
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 162
CALCITONIN DOWN-REGULATES IMMEDIATE CELL SIGNALS INDUCED IN HUMAN OSTEOCLAST-LIKE CELLS BY THE BONE SIALOPROTEIN-IIA FRAGMENT THROUGH A POSTINTEGRIN RECEPTOR MECHANISM 158
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 156
Effects of blocking urokinase receptor signaling by antisense oligonucleotides in a mouse model of experimental prostate cancer bone metastases 152
Osteoplastic activity of mature osteocytes evaluated by H-proline incorporation. 150
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 150
Genotype-phenotype relationship in human ATP6i-dependent autosomal recessive osteopetrosis 148
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 147
Improvement of the skeletal phenotype in a mouse model of diastrophic dysplasia after postnatal treatment with N-acetylcysteine 143
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 142
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 141
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 140
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 140
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 140
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy? 137
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 137
Oligodeoxynucleotide targeted to the alpha(v) gene inhibits alpha(v) integrin synthesis, impairs osteoclast function, and activates intracellular signals to apoptosis 135
Bone cells and the mechanisms of bone remodelling 135
Non-conventional role of haemoglobin beta in breast malignancy 135
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 133
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 131
The "love-hate" relationship between osteoclasts and bone matrix 131
Generation of the first autosomal dominant osteopetrosis type II (ADO2) disease models 129
CALCITONIN INCREASES CYTOSOLIC-FREE CALCIUM-CONCENTRATION VIA CAPACITATIVE CALCIUM INFLUX 129
Ultrastructural study of human adrenal pheochromocytoma by open needle biopsy. 127
Osteoblasts modulate secretion of urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) in human prostate cancer cells promoting migration and Matrigel invasion 127
Tyrosine kinase Src inhibitors: Potential therapeutic applications 127
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 127
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 126
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 126
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 126
Modulation of estrogen receptor levels in mouse uterus by protein kinase C isoenzymes 125
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 123
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 123
Osteoblast-derived TGF-beta1 modulates matrix degrading protease expression and activity in prostate cancer cells 123
Bone metastasis: pathogenesis and therapeutic implications 123
Increase in cytosolic Ca2+ induced by elevation of extracellular Ca2+ in skeletal myogenic cells 123
Type II benign osteopetrosis (Albers-Schonberg disease) caused by a novel mutation in CLCN7 presenting with unusual clinical manifestations 122
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 122
Transient estrogen exposure of female mice during early development permanently affects osteoclastogenesis in adulthood 122
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 122
Effects of advanced glycation end products on cytosolic Ca2+ signaling of cultured human mesangial cells 122
Signaling in osteoblasts integrates bone remodeling and energy metabolism 121
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 121
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 121
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 120
OSTEOCLAST CYTOSOLIC CALCIUM, REGULATED BY VOLTAGE-GATED CALCIUM CHANNELS AND EXTRACELLULAR CALCIUM, CONTROLS PODOSOME ASSEMBLY AND BONE-RESORPTION 120
P2RX7 Purinoceptor: A Therapeutic Target for Ameliorating the Symptoms of Duchenne Muscular Dystrophy 120
the effect of microgravity on osteoblast metabolism 120
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 120
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 120
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 120
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 120
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 120
Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin, bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent 119
Differentially expressed genes in autosomal dominant osteopetrosis type II osteoclasts reveal known and novel pathways for osteoclast biology 119
Tartronates: A new generation of drugs affecting bone metabolism 119
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 119
PLEKHM1 is involved in osteoclastic vesicular transport and mutations in this gene cause osteopetrosis in incisors absent rat and human 118
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 118
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 117
The Great Beauty of the osteoclast 117
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro 117
Melanoma cells stimulate osteoclastogenesis, c-src expression and osteoblast cytokines 117
Decreased c-Src expression enhances osteoblast differentiation and bone formation 117
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 117
An antisense oligonucleotide targeting the alpha V integrin gene inhibits adhesion and induces apoptosis in breast cancer cells 116
Osteoclast isolation: New developments and methods 116
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 116
THE EFFECTS OF PARATHYROID-HORMONE OR 1,25-DIHYDROXYVITAMIN-D3 ON MONOCYTE-OSTEOCLAST FUSION 115
Imbalance of osteoclastogenesis-regulating factors in celiac disease 115
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 115
Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: A new biological and clinical parameter for prostatic carcinoma 114
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 114
Colony stimulating factor-1-induced osteoclast spreading depends on substrate and requires the vitronectin receptor and the c-src proto-oncogene 114
OSTEOBLAST-OSTEOCLAST RELATIONSHIPS IN BONE-RESORPTION - OSTEOBLASTS ENHANCE OSTEOCLAST ACTIVITY IN A SERUM-FREE COCULTURE SYSTEM 113
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 113
Osteoblasts Regulate Angiogenesis in Response to Mechanical Unloading 113
Influence of calcium depletion on medullary bone of laying hens. 112
Mature osteocytes behaviour in a repletion period: the occurrence of osteoplastic activity. 112
Kinome profiling of osteoblasts on hydroxyapatite opens new avenues on biomaterial cell signaling 112
ROUS-SARCOMA VIRUS-TRANSFORMED FIBROBLASTS AND CELLS OF MONOCYTIC ORIGIN DISPLAY A PECULIAR DOT-LIKE ORGANIZATION OF CYTOSKELETAL PROTEINS INVOLVED IN MICROFILAMENT MEMBRANE INTERACTIONS 112
Congenital disorders of bone and blood 112
Role of Neural (N)-Cadherin in Breast Cancer Cell Stemness and Dormancy in the Bone Microenvironment 112
A six-gene signature predicting breast cancer lung metastasis 111
CALCIUM RELEASE-ACTIVATED CALCIUM INFLUX IN CULTURED HUMAN MESANGIAL CELLS 110
Immediate cell signal induced by laminin in rat Sertoli cells 110
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 109
ADHESION PROPERTIES AND INTEGRIN EXPRESSION OF CULTURED HUMAN OSTEOCLAST-LIKE CELLS 109
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 109
NEW MODEL FOR BONE-RESORPTION STUDY IN-VITRO - HUMAN OSTEOCLAST-LIKE CELLS FROM GIANT-CELL TUMORS OF BONE 109
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 109
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Association of intermediate osteopetrosis with poikiloderma 107
AUTORADIOGRAPHIC DEMONSTRATION OF INVITRO FUSION OF BLOOD MONOCYTES WITH OSTEOCLASTS 106
Osteoclast genetic diseases 106
Totale 12.592
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021468 0 0 0 0 0 0 0 0 0 0 363 105
2021/20221.438 89 136 343 91 62 39 33 83 103 26 77 356
2022/20233.649 285 188 69 368 349 419 5 279 1.499 14 116 58
2023/2024922 125 53 66 163 60 264 17 21 5 30 12 106
2024/20253.676 53 51 319 135 457 345 529 308 847 174 261 197
2025/20267.093 327 629 526 974 664 489 1.453 260 577 818 376 0
Totale 22.782